Articles tagged with Eastern Equine Encephalitis
Researchers at Washington University School of Medicine discovered a decoy molecule that protects against the potentially deadly brain infection. The study advanced understanding of viral protein and receptor interactions, laying a foundation for treatments and vaccines.
A vaccine candidate for eastern equine encephalitis virus, western equine encephalitis virus, and Venezuelan equine encephalitis virus has been found safe and well-tolerated in a clinical trial. The vaccine induced a neutralizing antibody response against all three viruses.
A new study identifies a set of cellular receptors for eastern equine encephalitis virus and other alphaviruses shared across mosquitoes, humans, and animals. The researchers tested a decoy molecule that successfully prevented infection and slowed disease progression in cell and animal models.
Eastern equine encephalitis virus is a deadly mosquito-borne illness that has existed for centuries, with a particularly deadly year in the US in 2019. Current research efforts focus on developing vaccines and treatments, but challenges include limited funding and difficulties in reaching target populations.
A significant outbreak of eastern equine encephalitis occurred in Panama in 2010, marking a change in the virus's behavior in Latin America. The outbreak confirmed 13 human cases and one dual infection case, with a low case-fatality rate compared to US standards.